Tissue engineering for cartilage injury and pathologies

CytexOrtho specializes in advanced orthopedic solutions, focusing on the development of innovative therapies for musculoskeletal conditions. The company employs cutting-edge technologies in tissue engineering and regenerative medicine to create products that enhance healing and recovery. Their approach includes the use of biomaterials and cellular therapies, which aim to improve the body’s natural repair mechanisms and provide effective treatments for joint and soft tissue injuries.

The company’s pipeline includes a range of products designed to address various orthopedic challenges, leveraging scientific research and clinical insights. CytexOrtho emphasizes the importance of collaboration with medical professionals and researchers to ensure that their technologies are not only effective but also aligned with the latest advancements in orthopedic science. Their commitment to rigorous testing and validation underscores their dedication to delivering safe and reliable solutions for patients suffering from musculoskeletal disorders.

CytexOrtho was formed to develop and commercialize the tissue regeneration technology discoveries coming out of the lab of Dr. Farshid Guilak at Duke University.  The original Cytex business plan received numerous innovation awards, including seed capital for the startup phase.  Since its founding, Cytex has gone on to win numerous state and federal grants, each recognizing the novelty of the research and its enormous potential contribution to the clinical management of patients with osteoarthritis. The three Cytex co-founders form the core leadership of the company as it continues to develop its novel products.

CytexOrtho

Company Details